Avenzo Therapeutics

About Avenzo Therapeutics

Avenzo Therapeutics is a company focused on developing the next generation of oncology therapies to transform cancer treatment. They are a passionate team of drug developers united by the purpose of delivering better medicines to cancer patients.

Products & Services

Oncology Therapies:Developing next-generation therapies aimed at transforming cancer treatment.

Pipeline for Solid Tumors:Taking a leading approach to tackle solid tumors using validated targets.

Specialties

Oncology Drug Development Solid Tumor Treatments

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 60000000 MR: - FA: 60 million FAN: 60000000	D: 2025-09-22 FD: 2025-09-22	14 investors
2	RT: Series A/A-1 T: - FT: Series A/A-1	A: 386000000 MR: - FA: approximately $386 million FAN: 386000000	D: 2024-11-18 FD: 2024-11-18	14 investors
3	RT: Series A-1 T: - FT: Series A-1	A: 150000000 MR: - FA: $150 million FAN: 150000000	D: 2024-03-26 FD: 2024-03-26	13 investors

Series B Latest

2025-09-22

$60.0M

14 investors (Pro only)

Series A/A-1 2024-11-18

$386.0M

Series A-1 2024-03-26

$150.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Athena Countouriotis, M.D.

Co-Founder, Chief Executive Officer, President, Chairperson

M

Mohammad Hirmand, M.D.

Co-Founder, Chief Medical Officer

P

Paolo Tombesi

Chief Financial Officer

B

Brian Sun, M.S., J.D.

Chief Legal Officer

S

Scott Lipman, M.B.A.

Chief Business Officer

H

Homa Yeganegi

Senior Vice President, Program and Portfolio Strategy and Medical Affairs

View 10 more team members with Pro

Unlock Full Team Directory

Recent News